UmbREALung - A Retrospective and Prospective, Observational, Real World Multi-cohort Study of Patients With Non-small Cell Lung Cancer (NSCLC) Initiating Approved Drugs Developed by AZ or as Part of an AZ Alliance

Clinical trial NCT06726720 · RECRUITING

Trial details

NCT number: NCT06726720
Sponsor: AstraZeneca
Status: RECRUITING
Study type: OBSERVATIONAL

Real World Multi-cohort Study of Patients With Non-small Cell Lung Cancer (NSCLC) Initiating Approved Drugs Developed by AZ or as Part of an AZ Alliance

Start date: 2024-12-16
Primary completion: 2032-06-30
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.